Skip to main content
. 2016 Sep 20;8(1):1774–1787. doi: 10.18632/oncotarget.12152

Figure 3. Kaplan-Meier analyses of the FIB-4 index in the negative alpha-fetoprotein (AFP) subgroup (u 20 ng/mL).

Figure 3

All patients were classified into two subgroups: low (FIB-4 I ≤ 3.25) and high (FIB-4 II > 3.25) scores. In the negative AFP subgroup (F 20 ng/mL), the FIB-4 index could predict OS A. and B. and RFS C. and D. in the testing A. and C. and validation B. and D. sets.